Skip to main content
O

ONCOSIL MEDICAL LTD — Investor Relations & Filings

Ticker · OSL ISIN · AU000000OSL3 ASX Manufacturing
Filings indexed 1,192 across all filing types
Latest filing 2026-04-27 Interim / Quarterly Rep…
Country AU Australia
Listing ASX OSL

About ONCOSIL MEDICAL LTD

https://www.oncosil.com

OncoSil Medical Ltd is a medical technology company focused on the development and commercialization of localized treatments for patients with unresectable cancers. The company's lead product, OncoSil, is a targeted radioactive isotope microparticle therapy designed to deliver a concentrated dose of beta radiation directly into solid tumors. It is primarily indicated for the treatment of locally advanced unresectable pancreatic cancer in combination with chemotherapy. The device utilizes Phosphorus-32 microparticles administered via endoscopic ultrasound-guided fine-needle injection, providing a localized brachytherapy approach intended to reduce tumor volume and improve surgical resectability. OncoSil Medical holds regulatory approvals in multiple jurisdictions, including the CE Mark for use in the European Union and the United Kingdom, and continues to evaluate clinical applications for other solid tumor types.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 815.9KB
Interim / Quarterly Report Q3 2026
2026-04-27 English
Change of Share Registry Details 2 pages 304.4KB
Regulatory Filings
2026-04-09 English
OSPREY Registry Data Accepted for Presentation at ESGE Days 2 pages 381.5KB
Regulatory Filings
2026-04-07 English
Change in substantial holding from SOL 7 pages 472.1KB
Regulatory Filings
2026-03-19 English
Late Lodgement of Appendix 3Y 5 pages 638.7KB
Regulatory Filings
2026-03-18 English
Change of Director's Interest Notice X2 6 pages 430.5KB
Regulatory Filings
2026-03-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.